On May 4, Jianfan Bio announced that it and the Wuhan Economic and Technological Development Zone Huanggang Industrial Park Management Committee, for Jianfan Bio in the Wuhan Economic and Technological Development Zone Huanggang Industrial Park, invested in the development of Jianfan biological blood purification products, The production base project started cooperation and signed the “Blood Purification Project Investment Framework Agreementâ€. According to the announcement, the fixed investment assets of the blood purification project are about 500 million yuan, and the total land area is about 160 mu, which is invested and constructed in two phases. Among them, the first phase mainly produces and researches hemodialysis products with an investment of about 300 million yuan. The land use scale is about 100 mu, the construction period is about 18 months, the product registration and trial production cycle is 18 months, and the post-production period is 2 In 3 years, the annual sales volume is expected to be 500 million yuan; the second phase is planned to be launched within three years after the first phase of the project is put into production, mainly producing and researching blood purification products, health products and nutritious foods, with an investment of about 200 million yuan. The scale is about 60 acres. After the completion of the two phases of the project, it is estimated that the annual sales value will be about 1.5 billion yuan. For this cooperation, Jianfan Bio said that it can expand its production capacity in the field of blood purification, give full play to the company's R&D and market advantages, and consolidate its position in the industry. At the same time, the company chose Wuhan Industrial Development Zone Huanggang Industrial Park to facilitate the use of Wuhan Central Hub, Yangtze River Water Transport, Wuhan Airport, Beijing-Kowloon Railway, etc., to radiate the central region, in line with the company's national layout of blood purification and health industry development strategy, the company's future business development Play a positive role. According to relevant information, Jianfan Bio is mainly engaged in the research and development, production and sales of blood perfusion related products, and independently develops disposable blood perfusion devices, disposable plasma bilirubin adsorbers, DNA immunosorbent columns and blood purification equipment. It is widely used in the fields of uremia, poisoning, severe liver disease, autoimmune diseases, and multiple organ failure. It was listed on the Shenzhen Stock Exchange on August 2, 2016. 1.uncut sheet for urine test low price Uncut Sheet,Uncut Sheet Strips,Rapid Uncut Sheet,Uncut Sheet Urine Strips Changchun LYZ Technology Co., Ltd , https://www.lyzinstruments.com
2.uncut sheet for urine test high quality
3.uncut sheet for urine test rapidly
4.uncut sheet for urine test OEM design welcome
The benefit to purchase rapid uncut sheet for urine test strip :
To help you saving the shipping cost
To help you being the manufacture
To help you saving the import tax as the materials
Our factory can supply more than 30 kinds of rapid test sheets
Package: aluminum foil package
Advantage: vacuum package can protect the effect of moisture